Chinese english Germany Japanese Korea

Clevidipine Impurity 17

Clevidipine Impurity 17 Struktur
1685245-63-9
CAS-Nr.
1685245-63-9
Englisch Name:
Clevidipine Impurity 17
Synonyma:
Clevidipine Impurity 17;Clevidipine butyrate-003;3-Buten-2-one, 4-(2,3-dichlorophenyl)-, (3E)-
CBNumber:
CB78176036
Summenformel:
C10H8Cl2O
Molgewicht:
215.08
MOL-Datei:
1685245-63-9.mol
Request For Quotation

Clevidipine Impurity 17 Eigenschaften

Siedepunkt:
339.4±32.0 °C(Predicted)
Dichte
1.280±0.06 g/cm3(Predicted)

Sicherheit

Clevidipine Impurity 17 Chemische Eigenschaften,Einsatz,Produktion Methoden

Clevidipine Impurity 17 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Clevidipine Impurity 17 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 10)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shanghai Kewel Chemical Co., Ltd. 021-64609169 18901607656
 greensnown@163.com China 9906 50
Shandong Chengchuang Blue Sea Pharmaceutical Technology Co., Ltd. 0531-58897130 15508676053
 drug_impurity@sdcclh.com China 1976 58
Jinan blalong chemical co. LTD 2710913286@.com
 1513643261@qq.com China 14246 58
Shanghai Lanc Pharmaceutical Technology Co., Ltd. 021-52216295 lankepharma
 3813332848@qq.com China 509 58
Hunan Zengda Biological Technology Co., LTD 18711085600
 1652923704@qq.com China 4582 58
Nanjing Huanuo Biomedical Technology Co., Ltd 18913906212
 2885426135@qq.com China 7010 58
Shanghai Haohong Scientific Co., Ltd. 400-400-8210725
malulu@leyan.com China 39990 58
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd 18502726233; 18502726233
 3641133981@qq.com China 9705 58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd 18162595016; 18162595016
 3287908757@qq.com China 9122 58
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd 18102736234 18102736234
 2208093734@qq.com China 7664 58
  • Clevidipine butyrate-003
  • 3-Buten-2-one, 4-(2,3-dichlorophenyl)-, (3E)-
  • Clevidipine Impurity 17
  • 1685245-63-9
Copyright 2019 © ChemicalBook. All rights reserved